Pilot study of Sirolimus (rapamycin) as primary immunosuppression following liver transplantation.

被引：0
|
作者：
Crosbie, OM [1 ]
Collier, J [1 ]
Bateman, E [1 ]
Watson, CJ [1 ]
Calne, R [1 ]
Gimson, AE [1 ]
Alexander, GJ [1 ]
机构：
[1] Univ Cambridge, Sch Clin Med, Cambridge, England
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
100
引用
收藏
页码：185A / 185A
页数：1
相关论文
共 50 条
  • [1] Experience with sirolimus (rapamycin) as primary immunosuppression post liver transplantation.
    Mallat, DB
    O'Brien, CB
    Rodriguez, MJ
    Pinna, AD
    Nery, JR
    Kato, T
    Schiff, ER
    Tzakis, AG
    HEPATOLOGY, 2000, 32 (04) : 343A - 343A
  • [2] Primary sirolimus based immunosuppression allows delayed use of CNI in liver transplantation.
    Lorf, T
    Weichhold, HE
    Binder, L
    Ramadori, G
    Quintel, M
    Becker, H
    LIVER TRANSPLANTATION, 2005, 11 (07) : C44 - C44
  • [3] The Impact of Sirolimus Immunosuppression on Recurrent Hepatitis C after Liver Transplantation.
    Asthana, Sonal
    Toso, Christian
    Meeberg, Glenda
    Mason, Andrew
    Bigam, David L.
    Shapiro, Andrew M. J.
    Kneteman, Norman M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 347 - 348
  • [4] Sirolimus as maintenance immunosuppression in pediatric intestinal transplantation.
    Safta, Arica M.
    Castillo, Ricardo O.
    Cox, Kenneth
    Esquivel, Carlos O.
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 78 - 78
  • [5] Mycophenolate mofetil with cyclosporine and prednisone as effective primary immunosuppression in children following liver transplantation.
    Lightdale, J
    Renz, JF
    Ascher, NL
    Emond, JC
    Rosenthal, P
    GASTROENTEROLOGY, 1997, 112 (04) : A1320 - A1320
  • [6] Sirolimus as a risk factor for incisional hernia following liver transplantation.
    Barnes, MT
    Singh, G
    Jabbour, N
    Genyk, Y
    Sher, L
    Selby, RR
    Mateo, R
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S164 - S164
  • [7] Everolimus maintenance immunosuppression for acute rejection following liver transplantation.
    Cheung, Fiona
    Li, Hanlin
    Tsapepas, Demetra
    Martin, Spencer
    Powell, Jaclyn
    PHARMACOTHERAPY, 2013, 33 (10): : E295 - E295
  • [8] Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma
    Zimmerman, Michael A.
    Trotter, James F.
    Wachs, Michael
    Bak, Tom
    Campsen, Jeffrey
    Skibba, Afshin
    Kam, Igal
    LIVER TRANSPLANTATION, 2008, 14 (05) : 633 - 638
  • [9] Minimizing immunosuppression in pediatric liver transplantation.
    Turmelle, Y.
    Nadler, M.
    Anderson, C.
    Lowell, J.
    Shepherd, R.
    PEDIATRIC TRANSPLANTATION, 2007, 11 : 111 - 111
  • [10] Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
    Zimmerman, Michael A.
    Trotter, James F.
    Wachs, Michael
    Bak, Tom
    Campsen, Jeffrey
    Kam, Igal
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 470 - 470
12345